enprofylline has been researched along with Hay Fever in 1 studies
enprofylline : Xanthine bearing a propyl substituent at position 3. A bronchodilator, it is used for the symptomatic treatment of asthma and chronic obstructive pulmonary disease, and in the management of cerebrovascular insufficiency, sickle cell disease, and diabetic neuropathy.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chung, KF | 1 |
| Barnes, PJ | 1 |
1 review available for enprofylline and Hay Fever
| Article | Year |
|---|---|
Respiratory and allergic disease. I.
Topics: Asthma; Bronchodilator Agents; Delayed-Action Preparations; Histamine H1 Antagonists; Humans; Nedocr | 1988 |